Cathy Tangen contributes to international study, finding on again-off again prostate cancer treatment has quality of life benefits, but continuous therapy improves overall survival
June 4, 2012
Many men with metastatic, hormone-sensitive prostate cancer live longer on continuous androgen-deprivation therapy (also known as hormone therapy) than on intermittent therapy, according to a 17-year study led by SWOG (formerly Southwest Oncology Group), a cancer research cooperative group.
Joseph Unger-led study finds poor patients stymied by financial, logistical concerns, blocking representation and access to latest therapies
June 4, 2012
According to a large study by the Fred Hutchinson Cancer Research Center’s SWOG (formerly the Southwest Oncology Group) cancer research cooperative group, cancer patients with annual household incomes below $50,000 were less likely to participate in clinical trials than higher income patients and were more likely to be concerned about how to pay for clinical trial participation.
Brian Till, research associate, studies mantle cell lymphoma
Sept. 21, 2009
Dr. Brian Till, of the Fred Hutchinson Cancer Research Center's Clinical Research Division, was among five early career researchers chosen by the Southwest Oncology Group to attend the group’s 2009 Young Investigator Training Course. The three-day workshop, which took place last week in Seattle, provided intensive training in how to design and conduct cancer clinical trials that may involve hundreds of patients at institutions throughout North America.